| Probiotics as Adjuvant Therapy in the Management of Irritable Bowel Syndrome (NCT05523427) | University of Mosul | 2022-07-19 |
| Comparing the Efficacy of Nitazoxanide Versus Rifaximin in Adult Patients With Irritable Bowel Syndrome Without Constipation (NCT05453916) | Sadat City University | 2022-07-01 |
| Evaluating the Safety and Efficacy of the Probiotic Bifidobacterium Longum ES1 and the Post Biotic Heat-treated Bifidobacterium Longum ES1 (HT-ES1) on IBS Symptom Severity in Patients With Diarrhoea Predominant Irritable Bowel Syndrome (NCT05339243) | Vedic Lifesciences Pvt. Ltd. | 2022-04-21 |
| Aldafermin (NGM282) for Chronic Diarrhea Due to Bile Acid Malabsorption (BAM) (NCT05130047) | Michael Camilleri, MD | 2021-12-01 |
| GI Permeability Change in Response to Aquamin® (NCT04855799) | James Varani | 2021-11-02 |
| Study on the Molecular Mechanism of Diarrhea-predominant Irritable Bowel Syndrome With Anxiety and Depression Based on Multi-omics Correlation Analysis (NCT05311293) | Tang-Du Hospital | 2021-11-01 |
| To Study the Efficacy and Safety of L. Plantarum UALp-05TM in Diarrhea- Predominant-irritable Bowel Syndrome (NCT04950296) | Vedic Lifesciences Pvt. Ltd. | 2021-09-16 |
| The Role of Fiber in the Prevention and Treatment of Fecal Incontinence (NCT04806386) | Massachusetts General Hospital | 2021-07-21 |
| Intestinal Permeability and Intestinal Microbiota in Irritable Bowel Syndrome (NCT05379036) | I.M. Sechenov First Moscow State Medical University | 2021-06-23 |
| Faecal Microbiota Transplantation in Irritable Bowel Syndrome (NCT04899869) | Thomayer University Hospital | 2021-06-17 |
| The Effects of Carbohydrates in Irritable Bowel Syndrome (NCT04830410) | Sahlgrenska University Hospital | 2021-03-30 |
| Efficacy and Safety of Rifaximin With NAC in IBS-D (NCT04557215) | Cedars-Sinai Medical Center | 2020-11-13 |
| Clinical Study to Evaluate the IBS Symptoms Improving Effect and Safety of GTB1 (NCT05277428) | Amorepacific Corporation | 2020-11-01 |
| Efficacy and Safety of Changkang Granule in the Treatment of Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) (NCT04492787) | Tasly Pharmaceutical Group Co., Ltd | 2020-07-06 |
| A Non-Interventional Pilot Study to Explore the Role of Gut Flora in IBS (NCT04214470) | ProgenaBiome | 2020-03-02 |
| Hydrogen Breath Test an Instrument to Predict Rifaximin-Response in Irritable Bowel Syndrome Predominant Diarrhea (NCT03729271) | University of Michigan | 2020-01-09 |
| A Comparison of the Effects of ORP-101 Versus Placebo in Adult Patients With Irritable Bowel Syndrome With Diarrhea (IBS-D) (NCT04129619) | OrphoMed, Inc. | 2019-11-22 |
| Multi Strain Probiotic Preparation in Patients With Irritable Bowel Syndrome (NCT04662957) | Children's Memorial Health Institute, Poland | 2019-11-02 |
| A Mediterranean Approach to Low FODMAP Diet (MED-LFD) for Managing IBS Symptoms (NCT03997708) | Attikon Hospital | 2019-07-01 |
| Lactobacillus LB as Treatment for Irritable Bowel Syndrome With Predominance of Diarrhea (IBS-D) (NCT04053790) | Hospital General de Mexico | 2019-01-15 |
| Interest of Pan Capsule in Symptomatic Patients Suspected of Irritable Bowel Syndrome Requiring Colonoscopy (NCT03806959) | Hospital Avicenne | 2018-11-07 |
| Changes in Microbiota and Metabolomic Profile Between Rifaximin Responders and Non-responders In Diarrhoea-Predominant Irritable Bowel Syndrome (NCT03557788) | National University Hospital, Singapore | 2018-05-07 |
| Eluxadoline Bile Acid Malabsorption (BAM) Study (NCT03441581) | Allergan | 2018-02-23 |
| Efficacy and Safety of a Food Supplement With Standardized Menthol, Limonene, and Gingerol Content in Patients With Irritable Bowel Syndrome (NCT04484467) | Federal Stare Budgetary Scientific Institution, Mental Health Research Center | 2018-02-09 |
| Trial to Understand Efficacy of Colesevelam in Diarrhea Predominant IBS Patients With Bile Acid Malabsorption (NCT03270085) | Mayo Clinic | 2017-12-07 |
| Effect of FODMAPs on Mucosal Inflammation in IBS Patients (NCT03221790) | Queen's University | 2017-11-01 |
| FODMAP Reintroduction in Irritable Bowel Syndrome (NCT03245645) | University of California, Los Angeles | 2017-03-24 |
| Efficacy of Eluxadoline in the Treatment of Irritable Bowel Syndrome With Diarrhea in Patients With Inadequate Control of Symptoms With Prior Loperamide Use (NCT02959983) | Allergan | 2016-10-25 |
| Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of BEKINDA (Ondansetron 12 mg Bimodal Release Tablets) for Diarrhea Predominant Irritable Bowel Syndrome (IBS-D) (NCT02757105) | RedHill Biopharma Limited | 2016-05-19 |
| The Efficacy of PX0612 In The Treatment Of Irritable Bowel Syndrome (NCT02431533) | Pharmabiotix Inc | 2016-01-01 |
| 12-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D) (NCT02320318) | Menarini Group | 2015-10-01 |
| 12-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D) (NCT02107196) | Menarini Group | 2014-03-01 |
| 52-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D) (NCT02120027) | Menarini Group | 2014-02-01 |
| Therapeutic Effect of Chang'an I Recipe on Irritable Bowel Syndrome With Diarrhea (NCT02822118) | Xiyuan Hospital of China Academy of Chinese Medical Sciences | 2013-01-01 |
| Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study (NCT01543178) | Bausch Health Americas, Inc. | 2012-02-01 |
| Ibodutant for Relief of Irritable Bowel Syndrome With Diarrhoea (IBS-D) (NCT01303224) | Menarini Group | 2010-10-01 |
| Mesalamine Granules for Irritable Bowel Syndrome (IBS) With Diarrhea (NCT01177410) | Bausch Health Americas, Inc. | 2010-07-01 |
| Post-Infectious Irritable Bowel Syndrome (PI-IBS) (NCT01497847) | KU Leuven | 2010-03-01 |
| Efficacy Study of Rezular (Arverapamil) in the Treatment of Irritable Bowel Syndrome With Diarrhea (IBS-D) (NCT00552565) | AGI Therapeutics, Inc. | 2007-09-01 |